• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
National Screening Institute

National Screening Institute

  • Home
  • About
    • About Us
    • About Our Test
  • Documents
    • Brochures
    • Research
  • Notebook
  • FAQs
  • Contact Us
  • Show Search
Hide Search

Oxidized LDL is the Key Molecule Directly Involved in the Development and Progression of Athrosclerotic Plaque

Download Study as a PDF
Download Study

The following article in the April 18, 2008 issue of Circulation describes oxLDL’s key role in atherosclerosis versus total cholesterol, LDL cholesterol, and triglycerides. The study used apolipoprotein E-deficient knockout mice. When fed a high fat diet their cholesterol increases substantially and, as a consequence, plaque lesions are formed rather rapidly. Next, the research team injected a receptor into the liver to reduce circulating oxLDL, and the lesions stabilized. The findings are summarized below:

Mice with high cholesterol (T-Cholesterol, LDL, Triglycerides) and high oxidized LDL had “markedly increased” atherosclerotic lesions.

Mice with high cholesterol (T-Cholesterol, LDL, Triglycerides) and low oxidized LDL had “complete protection” of atherosclerotic progression.

Reduction of oxidized LDL resulted in “complete prevention of atherosclerotic progression despite the persistence of severe LDL hypercholesterolemia and hypertriglyceridemia.”

Primary Sidebar

  • Notebook Introduction
  • 1 – Notebook Contents
  • 2 – CAD Hospitalizations with Normal LDL
  • 3 – Two Diagnostic Assays for Cardiovascular Disease
  • 4 – OxLDL In Acute and Stable CAD
  • 5 – OxLDL is the Key Molecule
  • 6 – OxLDL’s Role in the Atherosclerosis Process
  • 7 – OxLDL is the Most Accurate Biomarker
  • 8 – Association with Atherosclerosis
  • 9 – OxLDL Predictor of CAD
  • 10 – OxLDL Associated with Plaque
  • 11 – 4E6 is a Plaque-Specific Protein
  • 12 – Assays Based on Phospholipids
  • 13 – Patent Information
  • 14 – Market Potential
  • 15 – CAD, OxLDL and Diabetes

Footer

NATIONAL SCREENING INSTITUTE

Phone: 425-949-9170
Email: info@oxidized-ldl.com

Copyright © 2025 · National Screening Institute · Log in

Visit our Notebook for studies and other important information.